introduction integration pharmacogenetic testing routine care depend patients physicians acceptance tests empirical data regarding patients physicians views pharmacogenetic testing lacking objectives explore patients physicians perspectives potential implications pharmacogenetic testing particularly focusing asthma analyze possible determinants expectations hopes fears methods conducted telephone interviews patients asthma chronic obstructive pulmonary disease taking larger pharmacogenetic study addition general practitioners gps different region germany total NUMBER patients NUMBER gps invited participate determinants attitudes pharmacogenetic testing assessed using logistic regression analysis results informed consent participate study given NUMBER patients NUMBER NUMBER gps NUMBER patients NUMBER physicians NUMBER appreciated availability pharmacogenetic tests disease asthma approximately patients worried potential unfavorable test results NUMBER violation privacy NUMBER female patients likely fearful attitude odds ratio or285 NUMBER confidence interval younger patients generally likely hopeful usefulness pharmacogenetic testing or212 gps concerns mainly related possibility patients pressure tested NUMBER disadvantaged private health insurance agencies NUMBER nature responsible institution clarity research aim explicit informed consent patients influenced physicians decision regarding support pharmacogenetic study conclusion concerns patients gps differ somewhat respect negative psychosocial consequences discrimination violation privacy development information physicians patients helpful preventing unrealistic fears hopes ci158 NUMBER ci101 NUMBER